Stay updated with breaking news from Integrated Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/CNW/ - The Government of Ontario has committed $60 million dollars over a three-year period to support the Ontario Brain Institute (OBI) in its mission to...
/PRNewswire/ -- Baszucki Group today announced it has hired Kirk Nylen, PhD, as Managing Director, Neuroscience to oversee its growing research program. Prior...
Exploring a network pharmacological approach to verify the inflammation mechanisms of Hewei Jiangni granule in gastroesophageal reflux disease therapy.
Sleep Apnea Syndrome (SAS) is one of the most common chronic diseases, affecting nearly one billion people worldwide. The repetitive occurrence of abnormal respiratory events generates cyclical desaturation-reoxygenation sequences known as intermittent hypoxia (IH). Among SAS metabolic sequelae, it has been established by experimental and clinical studies that SAS is an independent risk factor for the development and progression of non-alcoholic fatty liver disease (NAFLD). The principal goal of this study was to decrypt the molecular mechanisms at the onset of IH-mediated liver injury. To add...
Michelle Sanchez, a senior professor of practice in the Tulane University School of Science and Engineering, has been named the winner of the Ada Lovelace STEM Educator Award for her contributions